Arteriocyte Takes the Lead in Promoting Building Future Pipeline of Women in STEM Career Fields
CLEVELAND, Dec. 13, 2011 /PRNewswire/ -- Don Brown, CEO of Arteriocyte Cellular Therapies Medical Systems (Arteriocyte) and Terri Sandu , Executive Director of Hard Hatted Women (HHW), are combining efforts to raise awareness of opportunities for women in Science, Technology, Engineering and Math (STEM) disciplines. They will inspire, celebrate and encourage women to choose careers and obtain the requisite education and training to thrive in STEM fields at a breakfast to be held tomorrow.
As a growing biotechnology company with a continual need for new, well-trained staff, Arteriocyte has always taken an active role in advancing the inclusion of women and minorities in STEM careers and education. While the percentage of women participating in these careers continues to increase, women still represent only 11% of working engineers and 32% of chemists.
WHEN: Wednesday, December 14, 2011, 8:00 am to 9:00 am
WHERE: Arteriocyte Research and Development Center, The Baker Electric Building:
7100 Euclid Avenue, Cleveland
About Arteriocyte:
Arteriocyte, a leading clinical stage biotechnology company, is dedicated in developing novel stem cell products and medical devices for unmet clinical needs. Arteriocyte leverages its expertise in stem cell and tissue engineering in order to develop a broad portfolio of cell based therapeutics to improve patient outcomes. In October of 2007, Arteriocyte partnered with DW Healthcare Partners and Comerica to create Arteriocyte Medical Systems Inc., in order to commercialize and distribute novel medical devices and point of care surgical solutions to address serious unmet medical needs in cardiac, orthopedic and vascular surgeries. Arteriocyte Medical Systems manufactures and distributes the Magellan™ Autologous Platelet Separator System.
About Hard Hatted Women:
Hard Hatted Women is a community based organization serving the state of Ohio dedicated to helping women get into and succeed in a broad range of non-traditional careers (where women are less than 25% of the workforce). Maintaining a continual strong presence in the Northeast Ohio region and the state since 1979, HHW boasts a long record of effectively assisting individuals, companies, and communities in reaching their goals for diversity and inclusiveness.
SOURCE Arteriocyte
More by this Source
Arteriocyte Receives FDA Approval to Initiate Cellular Therapy Trial for Treatment of Thermal Burn Wounds in Wounded Warriors
Jan 31, 2013, 10:37 ET
Featured Video
Journalists and Bloggers
![]()
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.





